Till today we do not have any medicine which can prevent kidney and ureteric stones. Japanese scientists have found that an experimental obesity drug can potentially prevent the formation of kidney stones in mice, a finding that paves the way to develop medications to prevent the condition in at-risk individuals. The findings showed that mice who were administered 1mg/kg of the beta3- agonist CL316243 for 12 days, showed a 17 percent decrease in the number of kidney stones than those who were not given the drug."This is an experimental work for now.
But I believe that this may open the way to the development of the new drugs which can stop the development of kidney stones in at-risk people," said lead researcher from the Nagoya City University Graduate School of Medical Sciences, Japan. "So far we have only tested this on mice, but in mice, it seems to work." We were able to analyze the…
